GlassScriptPhysician profile
Deborah L Behringer
NPI 1003094699
$913.93
in general payments reported to CMS, 2019-2025
8 companies · $733 in 2025
The $733 reported for 2025 was more than what 94% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.06 · 2023: $126 · 2024: $39.18 · 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $897.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $313.41 | 2022-2025 | Grafix, Renasys Go V2 Home, Collagenase Santyl |
| Organogenesis INC. | $176.78 | 2025 | Apligraf, Puraply Wound Matrix |
| Mimedx Group, INC. | $134.82 | 2025 | |
| Urgo Medical North America, LLC | $106.85 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Abbvie INC. | $91.69 | 2025 | |
| Convatec INC. | $47.27 | 2025 | |
| Integra Lifesciences Corporation | $23.17 | 2025 | Tcc-Ez |
| Tactile Systems Technology INC | $19.94 | 2025 | Flexitouch Plus, Nimbl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Behringer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.